From: Breast cancer stroma frequently recruits fetal derived cells during pregnancy
Patients/control individuals | Time of diagnosis | Term of diagnosis (months) | Neoadjuvant chemotherapy | pTNM | Size (mm) | Nodal status | Histology | Grade | Estrogen receptors | Presence of MC cells | Number of MC cells | Number of MC cells/10e6 maternal cells |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Patients | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   1 | Pregnancy | 2 | Yes | T3N0 | 60 | 3N+ | Ductal carcinoma | 3 | 1 | Positive | 16 | 8 |
   2 | Pregnancy | 7 | Yes | T4N0 | 4 6 | 15N-/15 | Ductal carcinoma | 3 | 0 | Positive | 20 | 78 |
   3 | Postpartum | 6 | No | T2N0 | 25 | 11N- | Ductal carcinoma | 3 | 0 | Positive | 3 | 7 |
   4 | Pregnancy | - | No | T3N1 | 30 | 14N+ | Ductal carcinoma | 3 | 0 | Positive | 23 | 24 |
   5 | Postpartum | 4 | No | T2N1 | 27 | 2N+ | Ductal carcinoma | 3 | 1 | Positive | 17 | 165 |
   6 | Postpartum | 3 | No | T2N1 | 5 | 24N- | Ductal carcinoma | 1 | 1 | Positive | 19 | 29 |
   7 | Pregnancy | 7 | Yes | T4D N3 | 80 | 24N+ | Ductal carcinoma | 3 | 0 | Positive | 21 | 16 |
   8 | Postpartum | 5 | Yes | T3N1 | 70 | 6N+ | Ductal carcinoma | 2 | 1 | Positive | 6 | 12 |
   9 | Postpartum | 1 | Yes | T2N1 | 40 | 13N- | Ductal carcinoma | 2 | 1 | Positive | 10 | 26 |
   10 | Pregnancy | 7 | Yes | T2N1 | 36 | N+ | Ductal carcinoma | 3 | 1 | Negative | 0 | 0 |
Controls | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   1 | Pregnancy | 4 | - | - | 70 | - | Mastosis | - | - | Negative | 0 | - |
   2 | Pregnancy | 4 | - | - | 28 | - | Fibroadenosis | - | - | Negative | 0 | - |
   3 | Pregnancy | 4 | - | - | 28 | - | Fibroadenosis | - | - | Negative | 0 | - |
   4 | Pregnancy | 4 | - | - | 22 | - | Fibroadenosis | - | - | Negative | 0 | - |